Urinary matrix metalloproteinase-7 is a sensitive biomarker to evaluate renal tubular injury in patients with minimal change disease and focal segmental glomerulosclerosis
- PMID: 38186883
- PMCID: PMC10765092
- DOI: 10.1093/ckj/sfad027
Urinary matrix metalloproteinase-7 is a sensitive biomarker to evaluate renal tubular injury in patients with minimal change disease and focal segmental glomerulosclerosis
Abstract
Objective: To explore the advantages of urinary matrix metalloproteinase-7 (MMP-7) in evaluating renal tubular injury in minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) patients compared with urinary cystatin C (CysC) and retinol-binding protein (RBP).
Methods: Serum and urine samples were collected from 20 healthy volunteers, and 40 MCD and 20 FSGS patients. Serum and urinary MMP-7 levels were measured by enzyme-linked immunosorbent assay. Urinary total protein, CysC and RBP levels were measured by automatic specific protein analyzer and compared with urinary creatinine level for calibration. The renal tissue serial sections were stained by MMP-7 immunohistochemistry and periodic acid-Schiff.
Results: Under light microscopy, MMP-7 granular weak positive expression was showed sporadically in the cytoplasm of a few renal tubular epithelial cells without obvious morphological changes in MCD patients, and MMP-7-positive expression was observed in the cytoplasm of some renal tubular epithelial cells in FSGS patients. There was no significant difference in serum MMP-7 level among the three groups. Compared with the control group, the urinary MMP-7 level in MCD patients was higher, but urinary CysC and RBP levels were not increased significantly. Compared with the control group and MCD patients, urinary MMP-7, CysC and RBP levels in FSGS patients were upregulated significantly.
Conclusions: Urinary MMP-7 could not only evaluate the mild renal tubular epithelial cells injury in MCD patients with massive proteinuria, but also evaluate the continuous renal tubular epithelial cells injury in FSGS patients.
Keywords: cystatin C; focal segmental glomerulosclerosis; matrix metalloproteinase-7; minimal change disease; renal tubular injury.
© The Author(s) 2023. Published by Oxford University Press on behalf of the ERA.
Conflict of interest statement
No conflicts of interest (financial or otherwise) are declared by the authors.
Figures


Similar articles
-
Urine MMP7 as a kidney injury biomarker.Clin Kidney J. 2023 Sep 14;17(1):sfad233. doi: 10.1093/ckj/sfad233. eCollection 2024 Jan. Clin Kidney J. 2023. PMID: 38186894 Free PMC article.
-
Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response.Nephron. 1998;79(1):44-9. doi: 10.1159/000044990. Nephron. 1998. PMID: 9609461
-
Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.Nephrol Dial Transplant. 2002 Nov;17(11):1890-6. doi: 10.1093/ndt/17.11.1890. Nephrol Dial Transplant. 2002. PMID: 12401843
-
Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis.BMC Nephrol. 2020 Apr 15;21(1):134. doi: 10.1186/s12882-020-01797-7. BMC Nephrol. 2020. PMID: 32293308 Free PMC article.
-
Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.Front Med (Lausanne). 2018 Jun 11;5:170. doi: 10.3389/fmed.2018.00170. eCollection 2018. Front Med (Lausanne). 2018. PMID: 29942802 Free PMC article. Review.
Cited by
-
Matrix metalloproteinases in kidney homeostasis and diseases: an update.Am J Physiol Renal Physiol. 2024 Dec 1;327(6):F967-F984. doi: 10.1152/ajprenal.00179.2024. Epub 2024 Oct 3. Am J Physiol Renal Physiol. 2024. PMID: 39361724 Review.
-
Integrated multiomic analyses: An approach to improve understanding of diabetic kidney disease.Diabet Med. 2025 Feb;42(2):e15447. doi: 10.1111/dme.15447. Epub 2024 Oct 26. Diabet Med. 2025. PMID: 39460977 Free PMC article. Review.
-
Urine MMP7 as a kidney injury biomarker.Clin Kidney J. 2023 Sep 14;17(1):sfad233. doi: 10.1093/ckj/sfad233. eCollection 2024 Jan. Clin Kidney J. 2023. PMID: 38186894 Free PMC article.
References
-
- Lin SP, Meng JL, Sun XW et al. [Clinical characteristics and related factors of acute tubular necrosis in patients with minimal change disease]. Zhonghua Yi Xue Za Zhi 2020;100:3494–7. - PubMed
LinkOut - more resources
Full Text Sources